Year-end Sale % OFF 
Abstract
To improve the degradation ability of anaerobic granular sludge (AGS) toward the iodinated contrast media (ICM) iohexol, biogenic nanoscale palladium (Pd) was formed in AGS via microbial reduction. The Pd hosted in AGS (Pd-AGS) was used for iohexol degradation. The effects of the electron donor, reaction medium, iodide ion fouling, and polymer embedding of the Pd-AGS on the reactivity were investigated. Our results showed the Pd-AGS increased the degradation rate of iohexol, with a conversion rate constant increased by 86.3-fold compared to the AGS control. Various organic compounds were investigated as electron donors to initiate the catalytic activity of Pd-AGS and the promotion achieved with the tested electron donors was in the following order: formate > lactate > ethanol > glucose > acetate. The Pd-AGS had high reactivity in deionized water at mild pH, and almost no reactivity under acidic (pH = 1.2) and alkaline (pH > 11) conditions. The presence of iodide ions in the medium inhibited the catalytic activity of Pd-AGS toward iohexol because of catalyst fouling. Embedding the Pd-AGS in alginate, chitosan, or polyvinyl alcohol (PVA) could prevent Pd loss but it also retarded the iohexol degradation rate. The Pd-AGS, as a combination of Pd catalyst and AGS, provides a novel strategy for iohexol degradation in polluted water and wastewater.
Highlights
Iodinated contrast media (ICM) are a widely used class of pharmaceuticals for imaging in radiological and medical diagnoses (Perez and Barcelo, 2007)
11% of the iohexol was removed by the anaerobic granular sludge (AGS) control after 12 h in the presence of formate
The results showed that the presence of iodide ions retarded iohexol degradation significantly (p < 0.05), and the kinetic rate constant decreased by 45–73% compared with that in the DI water (Figure 7A)
Summary
Iodinated contrast media (ICM) are a widely used class of pharmaceuticals for imaging in radiological and medical diagnoses (Perez and Barcelo, 2007). ICM compounds are often released to wastewater treatment systems via urine excreted from the human body. As ICM are generally metabolically stable, they can hardly be degraded in conventional biological wastewater treatment systems. Iohexol is a typical ICM, and is often used as diagnostic iodinated contrast agent in high doses in hospitals. In one standard Swiss university hospital, iohexol consumption reached 725 g/day (Weissbrodt et al, 2009) and half this was discharged in wastewater. The concentration of iohexol detected in surface water bodies and wastewater effluent is in a range from ng/L to μg/L, which will pose a high risk to the environmental biota (Chèvre, 2014)
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
